Chemotherapy response ccore (CRS) combined with clinical characteristics predict prognosis in high-grade serous ovarian carcinoma (HGSOC) patients with neoadjuvant chemotherapy

被引:0
作者
Xu, Qin [1 ]
Liu, Jing [2 ]
Pan, Junping [2 ]
Song, Yanwen [2 ]
Luo, Lan [2 ]
Hu, Dan [2 ]
机构
[1] Fujian Med Univ, Fujian Canc Hosp, Canc Hosp, Fuzhou, Peoples R China
[2] Fujian Med Univ, Fujian Canc Hosp, Clin Oncol Sch, Fuzhou, Peoples R China
关键词
D O I
10.1016/j.ygyno.2023.06.203
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
1299
引用
收藏
页码:S185 / S185
页数:1
相关论文
empty
未找到相关数据